Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Conference Preview: 2026 GOLD International COPD Conference Tim Smith

Published Date: 06 Nov 2026

HCPLive previews GOLD 2026 in Philadelphia, November 5-6, with sessions on the 2027 GOLD Report, mucus plugging, and exacerbations, plus expert interviews.

7 Pulmonology Headlines You Missed in October

Published Date: 06 Nov 2026

7 Pulmonology Headlines You Missed in October

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

Published Date: 06 Nov 2026

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD

Published Date: 06 Nov 2026

Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD

Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk

Published Date: 06 Nov 2026

Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk

Analyzing Inebilizumab’s Durable Benefit in MINT Open-Label Extension Marco Meglio

Published Date: 06 Nov 2026

Richard Nowak, MD, director of the Yale Myasthenia Gravis Clinic and global principal investigator of the MINT trial, discusses open-label extension findings for inebilizumab, a CD19-directed B cell depleting therapy, in generalized myasthenia gravis.

Final Results Reported for EPISOD1 Trial of SOD1-ALS Gene Therapy AMT-162 Marco Meglio

Published Date: 06 Nov 2026

uniQure presented final safety and biomarker results from the discontinued EPISOD1 trial of AMT-162, an investigational gene therapy for SOD1-associated ALS.

IJMSC Webinar Series Guides MS Clinicians From Idea to Publication Matt Hoffman

Published Date: 06 Nov 2026

IJMSC editor-in-chief, François Bethoux, MD, and colleagues cover idea generation, poster conversion, literature reviews, and peer review in a 4-part webinar series for MS clinicians.

CONCORD Trial Results in CKD Depression, With Susan Hedayati, MD, MHSc

Published Date: 06 Nov 2026

CONCORD Trial Results in CKD Depression, With Susan Hedayati, MD, MHSc

8 Nephrology Headlines You Missed in October 2026

Published Date: 06 Nov 2026

8 Nephrology Headlines You Missed in October 2026

Knowledge Hub

Oncology

Tumor-Associated Macrophage Iron Recycling and Its Influence on Local Antitumor Immune Activity

A medical review of how tumor-associated macrophage iron recycling shapes local antitumor immunity, tumor progression, biomarkers, and emerging therapies.

Oncology

Engineered Lymphoid Tissue Niches for Reconstructing Immune-Supportive Microenvironments After Cancer Treatment

A medical review of engineered lymphoid tissue niches for restoring immune function after cancer treatment, including mechanisms, clinical applications, risks, and emerging research.

Oncology

Monitoring Delayed Toxicities of Cellular Cancer Therapies

A clinical review of delayed toxicities after cellular cancer therapy, including mechanisms, risk factors, diagnosis, management, and guideline-based long-term surveillance.

Oncology

Genomic Determinants of Tumor Cell Dormancy in Minimal Residual Cancer Disease

A medical review of genomic, epigenetic, immune, and microenvironmental mechanisms governing tumor dormancy in minimal residual cancer disease.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Conference Preview: 2026 GOLD International COPD Conference Tim Smith

7 Pulmonology Headlines You Missed in October

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD

Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk

Analyzing Inebilizumab’s Durable Benefit in MINT Open-Label Extension Marco Meglio

Final Results Reported for EPISOD1 Trial of SOD1-ALS Gene Therapy AMT-162 Marco Meglio

IJMSC Webinar Series Guides MS Clinicians From Idea to Publication Matt Hoffman

CONCORD Trial Results in CKD Depression, With Susan Hedayati, MD, MHSc

8 Nephrology Headlines You Missed in October 2026

Knowledge Hub

Tumor-Associated Macrophage Iron Recycling and Its Influence on Local Antitumor Immune Activity

Engineered Lymphoid Tissue Niches for Reconstructing Immune-Supportive Microenvironments After Cancer Treatment

Monitoring Delayed Toxicities of Cellular Cancer Therapies

Genomic Determinants of Tumor Cell Dormancy in Minimal Residual Cancer Disease

Therapeutic Advances in Tumor Nutrient-Deprivation Strategies

Virtual Oncology Survivorship Support Networks: Evidence, Clinical Integration, and Future Directions

Precision Selection of Cancer Surgery Versus Organ-Preserving Treatment Using Patient-Specific Functional Priorities

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Conference Preview: 2026 GOLD International COPD Conference Tim Smith

7 Pulmonology Headlines You Missed in October

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD

Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk

Analyzing Inebilizumab’s Durable Benefit in MINT Open-Label Extension Marco Meglio

Final Results Reported for EPISOD1 Trial of SOD1-ALS Gene Therapy AMT-162 Marco Meglio

IJMSC Webinar Series Guides MS Clinicians From Idea to Publication Matt Hoffman

CONCORD Trial Results in CKD Depression, With Susan Hedayati, MD, MHSc

8 Nephrology Headlines You Missed in October 2026

Knowledge Hub

Tumor-Associated Macrophage Iron Recycling and Its Influence on Local Antitumor Immune Activity

Engineered Lymphoid Tissue Niches for Reconstructing Immune-Supportive Microenvironments After Cancer Treatment

Monitoring Delayed Toxicities of Cellular Cancer Therapies

Genomic Determinants of Tumor Cell Dormancy in Minimal Residual Cancer Disease

Therapeutic Advances in Tumor Nutrient-Deprivation Strategies

Virtual Oncology Survivorship Support Networks: Evidence, Clinical Integration, and Future Directions

Precision Selection of Cancer Surgery Versus Organ-Preserving Treatment Using Patient-Specific Functional Priorities

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views